09:57 AM EST - Numinus Wellness Inc : Has completed key steps to prepare to enroll participants at its clinics participating in "A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD (MAPPUSX)", sponsored by the Multidisciplinary Association for Psychedelic Studies. Numinus Wellness Inc
shares T.NUMI are trading up $0.01 at $0.71.
